Lin G.

Lin G. is a highly experienced professional in the pharmaceutical industry, currently serving as the Sr. Director and Head of Medical Writing and Trial Transparency & Disclosure at Insmed Incorporated since September 2018, following roles as Director and Associate Director in the same domain. Previous experience includes a managerial position in medical writing at Sanofi from January 2016 to August 2018 and a regulatory affairs role at Genpact Pharmalink. Lin's earlier career includes significant contributions at Roche, managing multiple projects across various therapeutic areas, and serving as a Novartis CEO Postdoctoral Fellow. Educational qualifications include a Ph.D. in Molecular Pharmacology from Stanford University School of Medicine, a BS in Biochemistry from Cornell University, and additional studies at Stony Brook University.